Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 21, 2008. The document serves as a notification of transactions involving directors and persons discharging managerial responsibility under the Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document is limited to reporting specific share transactions.
Material Changes
The filing reports an increase in share interests for five individuals following the re-investment of dividends paid on October 9, 2008. The shares were purchased on October 15, 2008, at a price of £11.03 per share. The specific increases are:
- Mr A P Witty: 120 shares
- Dr M M Slaoui: 265 shares
- Mr M Dunoyer: 128 shares
- Dr D Pulman: 196 shares
- Ms C Thomas: 49 shares
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Points
- Confirm the total number of shares held by the listed directors post-transaction.
- Verify the dividend reinvestment plan terms applicable to the October 9, 2008 dividend.
- Check the market price of GSK shares on October 15, 2008, to contextualize the £11.03 purchase price.